The type of the first prime/boost vaccine against SARS-CoV-2 exerts long-term effects on the humoral immune response

被引：0

作者：

Mai, Franz ^{[1
]}

Reisinger, Emil C. ^{[2
]}

Mueller-Hilke, Brigitte ^{[1
]}

机构：

[1] Rostock Univ, Med Ctr, Core Facil Cell Sorting & Cell Anal, D-18057 Rostock, Germany

[2] Rostock Univ, Ctr Internal Med 2, Div Trop Med & Infect Dis, Med Ctr, D-18055 Rostock, Germany

来源：

CLINICAL IMMUNOLOGY | 2025年 / 278卷

关键词：

SARS-CoV-2; COVID-19; BNT162b2; AZD1222; Immune imprinting; Breakthrough infection;

D O I：

10.1016/j.clim.2025.110523

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The outbreak of COVID-19 spurred the development of different vaccines against SARS-CoV-2 however, recommendations on how to maintain long-term protection from COVID-19 remain elusive. We here report on a cohort of 192 health care workers receiving their primary vaccination with either AZD1222 or BNT162b2. Over the course of three years, six blood samples were taken and analyzed for antibody dynamics against the receptor binding domain of the Spike protein and for function via surrogate virus neutralization. Our results showed that higher anti SARS-CoV-2 S titers correlated with increased neutralizing capacity and ameliorated COVID-19 disease. The type of the first prime/boost vaccine exerted long term effects with a homologous BNT162b2 regimen outperforming AZD1222 in terms of antibody titers and neutralizing capacity. This deficit for AZD1222 was not compensated for by subsequent boosting with RNA vaccines, was still evident after three years, and is discussed in the context of immune imprinting.

引用

页数：8

共 47 条

[1]

Aguilar-Bretones Muriel, 2023, J Clin Invest, V133, DOI 10.1172/JCI162192

[2] Long COVID science, research and policy [J].

Al-Aly, Ziyad ;

Davis, Hannah ;

McCorkell, Lisa ;

Soares, Leticia ;

Wulf-Hanson, Sarah ;

Iwasaki, Akiko ;

Topol, Eric J. .

NATURE MEDICINE, 2024, 30 (08) :2148-2164

[3] Persistence of immunity against Omicron BA.1 and BA.2 variants following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-dose AZD1222 vaccination [J].

Assawakosri, Suvichada ;

Kanokudom, Sitthichai ;

Chansaenroj, Jira ;

Suntronwong, Nungruthai ;

Auphimai, Chompoonut ;

Nilyanimit, Pornjarim ;

Vichaiwattana, Preeyaporn ;

Thongmee, Thanunrat ;

Duangchinda, Thaneeya ;

Chantima, Warangkana ;

Pakchotanon, Pattarakul ;

Srimuan, Donchida ;

Thatsanatorn, Thaksaporn ;

Klinfueng, Sirapa ;

Sudhinaraset, Natthinee ;

Mongkolsapaya, Juthathip ;

Wanlapakorn, Nasamon ;

Honsawek, Sittisak ;

Poovorawan, Yong .

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 122 :793-801

[4] Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].

Baden, Lindsey R. ;

El Sahly, Hana M. ;

Essink, Brandon ;

Kotloff, Karen ;

Frey, Sharon ;

Novak, Rick ;

Diemert, David ;

Spector, Stephen A. ;

Rouphael, Nadine ;

Creech, C. Buddy ;

McGettigan, John ;

Khetan, Shishir ;

Segall, Nathan ;

Solis, Joel ;

Brosz, Adam ;

Fierro, Carlos ;

Schwartz, Howard ;

Neuzil, Kathleen ;

Corey, Larry ;

Gilbert, Peter ;

Janes, Holly ;

Follmann, Dean ;

Marovich, Mary ;

Mascola, John ;

Polakowski, Laura ;

Ledgerwood, Julie ;

Graham, Barney S. ;

Bennett, Hamilton ;

Pajon, Rolando ;

Knightly, Conor ;

Leav, Brett ;

Deng, Weiping ;

Zhou, Honghong ;

Han, Shu ;

Ivarsson, Melanie ;

Miller, Jacqueline ;

Zaks, Tal .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416

[5] A heterologous AZD1222 priming and BNT162b2 boosting regimen more efficiently elicits neutralizing antibodies, but not memory T cells, than the homologous BNT162b2 regimen [J].

Baek, Yae Jee ;

Kim, Woo-Joong ;

Ko, Jae-Hoon ;

Lee, Youn-Jung ;

Ahn, Jin Young ;

Kim, Jung Ho ;

Jang, Ho Cheol ;

Jeong, Hye Won ;

Kim, Yong Chan ;

Park, Yoon Soo ;

Kim, Sung -Han ;

Peck, Kyong Ran ;

Shin, Eui-Cheol ;

Choi, Jun Yong .

VACCINE, 2023, 41 (10) :1694-1702

[6] Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination [J].

Barros-Martins, Joana ;

Hammerschmidt, Swantje, I ;

Cossmann, Anne ;

Odak, Ivan ;

Stankov, Metodi, V ;

Ramos, Gema Morillas ;

Dopfer-Jablonka, Alexandra ;

Heidemann, Annika ;

Ritter, Christiane ;

Friedrichsen, Michaela ;

Schultze-Florey, Christian ;

Ravens, Inga ;

Willenzon, Stefanie ;

Bubke, Anja ;

Ristenpart, Jasmin ;

Janssen, Anika ;

Ssebyatika, George ;

Bernhardt, Gunter ;

Muench, Jan ;

Hoffmann, Markus ;

Poehlmann, Stefan ;

Krey, Thomas ;

Bosnjak, Berislav ;

Foerster, Reinhold ;

Behrens, Georg M. N. .

NATURE MEDICINE, 2021, 27 (09) :1525-+

[7] BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19 [J].

Behrens, Georg M. N. ;

Barros-Martins, Joana ;

Cossmann, Anne ;

Ramos, Gema Morillas ;

Stankov, Metodi, V ;

Odak, Ivan ;

Dopfer-Jablonka, Alexandra ;

Hetzel, Laura ;

Koehler, Miriam ;

Patzer, Gwendolyn ;

Binz, Christoph ;

Ritter, Christiane ;

Friedrichsen, Michaela ;

Schultze-Florey, Christian ;

Ravens, Inga ;

Willenzon, Stefanie ;

Bubke, Anja ;

Ristenpart, Jasmin ;

Janssen, Anika ;

Ssebyatika, George ;

Kraehling, Verena ;

Bernhardt, Guenter ;

Hoffmann, Markus ;

Poehlmann, Stefan ;

Krey, Thomas ;

Bosnjak, Berislav ;

Hammerschmidt, Swantje, I ;

Foerster, Reinhold .

NATURE COMMUNICATIONS, 2022, 13 (01)

[8] Original antigenic sin: A potential double-edged effect for vaccine improvement [J].

Ding, Xuan ;

Zhao, Feijun ;

Liu, Zhaoping ;

Yao, Jiangchen ;

Yu, Han ;

Zhang, Xiaohong .

BIOMEDICINE & PHARMACOTHERAPY, 2024, 178

[9] Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection [J].

Feng, Shuo ;

Phillips, Daniel J. ;

White, Thomas ;

Sayal, Homesh ;

Aley, Parvinder K. ;

Bibi, Sagida ;

Dold, Christina ;

Fuskova, Michelle ;

Gilbert, Sarah C. ;

Hirsch, Ian ;

Humphries, Holly E. ;

Jepson, Brett ;

Kelly, Elizabeth J. ;

Plested, Emma ;

Shoemaker, Kathryn ;

Thomas, Kelly M. ;

Vekemans, Johan ;

Villafana, Tonya L. ;

Lambe, Teresa ;

Pollard, Andrew J. ;

Voysey, Merryn .

NATURE MEDICINE, 2021, 27 (11) :2032-+

[10] Humoral and cellular immune response over 9 months of mRNA-1273, BNT162b2 and ChAdOx1 vaccination in a University Hospital in Spain [J].

Fernandez-Ciriza, Leire ;

Gonzalez, Alvaro ;

del Pozo, Jose Luis ;

Fernandez-Montero, Alejandro ;

Carmona-Torre, Francisco ;

Carlos, Silvia ;

Sarasa, Maria del Mar ;

Reina, Gabriel .

SCIENTIFIC REPORTS, 2022, 12 (01)

← 1 2 3 4 5 →